Sabra Health Care REIT, Inc. (SBRA)
- Previous Close
13.66 - Open
13.67 - Bid 13.72 x 500
- Ask 13.79 x 600
- Day's Range
13.65 - 13.85 - 52 Week Range
10.30 - 14.91 - Volume
1,569,435 - Avg. Volume
2,098,779 - Market Cap (intraday)
3.19B - Beta (5Y Monthly) 1.17
- PE Ratio (TTM)
229.67 - EPS (TTM)
0.06 - Earnings Date May 1, 2024 - May 6, 2024
- Forward Dividend & Yield 1.20 (8.71%)
- Ex-Dividend Date Feb 12, 2024
- 1y Target Est
15.91
As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing - Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2023, Sabra's real estate properties held for investment included 37,606 beds/units, spread across the United States and Canada.
www.sabrahealth.com48
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: SBRA
Performance Overview: SBRA
Trailing total returns as of 4/23/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SBRA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SBRA
Valuation Measures
Market Cap
3.19B
Enterprise Value
5.56B
Trailing P/E
229.67
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
4.95
Price/Book (mrq)
1.14
Enterprise Value/Revenue
8.59
Enterprise Value/EBITDA
17.84
Financial Highlights
Profitability and Income Statement
Profit Margin
2.13%
Return on Assets (ttm)
2.45%
Return on Equity (ttm)
0.47%
Revenue (ttm)
644.62M
Net Income Avi to Common (ttm)
13.76M
Diluted EPS (ttm)
0.06
Balance Sheet and Cash Flow
Total Cash (mrq)
60.2M
Total Debt/Equity (mrq)
86.59%
Levered Free Cash Flow (ttm)
245.38M
Research Analysis: SBRA
Company Insights: SBRA
Fair Value
Dividend Score
Hiring Score
Insider Sentiment Score
Research Reports: SBRA
SBRA: Lowering target price to $14.00
SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetSBRA: What does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetSBRA: What does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice TargetSBRA: What does Argus have to say about SBRA?
SABRA HEALTH CARE REIT INC has an Investment Rating of HOLD; a target price of $15.000000; an Industry Subrating of Low; a Management Subrating of High; a Safety Subrating of High; a Financial Strength Subrating of High; a Growth Subrating of Medium; and a Value Subrating of Low.
RatingPrice Target